Large And Small-Scale Bioprocessing Market Growth To $119.99 Billion By 2030: What’s Driving The Expansion?

Large And Small-Scale Bioprocessing Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Large And Small-Scale Bioprocessing Market Revenue Growth On Track For A 11.8% CAGR Through 2030

The large and small-scale bioprocessing market size has experienced significant growth in recent years. It is anticipated to expand from $67.66 billion in 2025 to $76.73 billion in 2026, at a compound annual growth rate (CAGR) of 13.4%. This historical growth can be ascribed to several factors, including the expansion of biopharmaceutical manufacturing, increasing investment in biotechnology R&D, the broadening of fermentation-based production, the rising adoption of cell culture technologies, and the development of large-scale stainless steel bioreactors.

The large and small-scale bioprocessing market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $119.99 billion, demonstrating a compound annual growth rate (CAGR) of 11.8%. Factors driving this growth during the forecast period include a heightened demand for biologics and biosimilars, a growing embrace of single-use technologies, the advancement of personalized and precision medicine, an increase in CDMO services, and a greater emphasis on environmentally friendly bioprocessing techniques. Key trends observed during this period encompass the increasing integration of single-use and modular bioprocessing systems, an escalating need for adaptable small-scale bioprocessing in research and development, the broadening scope of contract biomanufacturing and outsourcing frameworks, an intensified drive towards achieving process scalability from laboratory to commercial production, and enhanced synergy between upstream and downstream bioprocess operations.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=13975197&type=smp&name=Large%20And%20Small-Scale%20Bioprocessing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Large And Small-Scale Bioprocessing Market Industry Drivers: What’s Behind The Revenue Growth?

The increasing need for biologics is anticipated to drive the expansion of the large and small-scale bioprocessing market in the future. Biologics are defined as medical products originating from living organisms or their parts, encompassing vaccines, blood and its constituents, gene therapies, tissues, and recombinant therapeutic proteins. This rising demand for biologics stems from progress in biotechnology, improved comprehension of disease mechanisms, and the quest for targeted and individualized treatments. Both large-scale and small-scale bioprocessing play crucial roles in the successful development and commercialization of biologics. Small-scale bioprocessing is vital for initial development phases, optimization efforts, and feasibility assessments. Conversely, large-scale bioprocessing guarantees the efficient, consistent production of biologics, adhering to regulatory standards for their commercial distribution. For example, data from the National Library of Medicine, a US-based medical library, indicated that in February 2024, the Food and Drug Administration (FDA) had approved 55 new drugs in 2023. These approvals comprised 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), representing a 50% increase from the 37 approvals recorded in 2022. Consequently, the increasing requirement for biologics fuels the expansion of the large and small-scale bioprocessing market.

Large And Small-Scale Bioprocessing Market Breakdown By Product Type And Application

The large and small-scale bioprocessing market covered in this report is segmented –

1) By Product: Bioreactors Or Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags And Containers, Other Products

2) By Mode: In-house, Outsourced

3) By Workflow: Downstream Processing, Fermentation, Upstream Processing

4) By Scale: Industrial Scale, Small Scale

5) By Application: Biopharmaceuticals, Specialty Industrial Chemicals, Environmental Aids

Subsegments:

1) Bioreactors Or Fermenters: Single-Use Bioreactors, Stainless Steel Bioreactors, Glass Bioreactors

2) Cell Culture Products: Cell Culture Media, Sera And Supplements, Reagents

3) Filtration Assemblies: Membrane Filters, Depth Filters, Tangential Flow Filtration Systems

4) Bioreactor Accessories: Spargers, Impellers, Sensors And Probes

5) Bags And Containers: Single-Use Bags, Storage Containers, Transfer Bags

6) Other Products: Mixers, Tubing And Connectors, Sampling Systems

#Large And Small-Scale Bioprocessing Market Growth Trends: What’s Shaping The Future Outlook?

Leading entities within the large and small-scale bioprocessing market are concentrating on creating novel solutions, including fixed-bed, low-footprint bioreactor controllers. This effort aims to satisfy the growing need for highly productive, cost-effective, and scalable manufacturing of viral vectors and advanced therapies, a demand fueled by the expansion of gene therapies, vaccines, and biologics. These controllers are specialized hardware units designed to manage large-area cell culture within fixed-bed reactors. They provide a compact design, an easy-to-use interface, and efficient fluid handling, standing apart from conventional large-scale stirred-tank bioreactors that require significant physical space, high initial investment, and intricate infrastructure. As an illustration, in May 2025, Univercells Technologies SA, a bioprocessing firm based in Belgium, introduced the scale-X Nitro Controller. This device is specifically engineered to operate their 200 m² and 600 m² scale-X Nitro fixed-bed bioreactors. This controller is a compact, wheeled apparatus with a 1.6 m² footprint, allowing it to pass through standard cleanroom entrances. It supports both adherent and suspension cell cultures and provides highly straightforward control. It facilitates quick scaling from research and development to commercial production, achievable in approximately 8 months, simultaneously lowering the cost-of-goods by 36–82% when contrasted with conventional adherent methods. By integrating high productivity with a simplified, space-efficient design, the scale-X Nitro Controller assists biomanufacturers, particularly CDMOs and vaccine developers, in accelerating their development schedules and reducing the financial hurdle for large-scale viral manufacturing.

Large And Small-Scale Bioprocessing Market Company Landscape And Competitive Strategy

Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Eli Lilly and Company, AbbVie Inc., Amgen Inc., Biogen Inc., Regeneron Pharmaceuticals Inc., Genentech Inc., Gilead Sciences Inc., Novo Nordisk A/S, CSL Limited, UCB S.A., Samsung Biologics, WuXi Biologics, Boehringer Ingelheim

View The Full Large And Small-Scale Bioprocessing Market Report:

https://thebusinessresearchcompany.com/report/large-and-small-scale-bioprocessing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Large And Small-Scale Bioprocessing Market Geographic Spread And Regional Opportunities

North America was the largest region in the large and small-scale bioprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model